U.S. FDA says current COVID vaccines not 'well-matched' against BA.2 variant

FILE PHOTO: A health care worker points to a man wearing a protective face mask while waiting in line to receive one of the available first, second and booster doses of the coronavirus disease (COVID-19) vaccine at the L.A. Care Health Plan free testing and vaccination site at the First African Episcopal Church in Los Angeles, California, U.S., January 29, 2022. REUTERS/Shannon Stapleton

(Reuters) – The U.S. Food and Drug Administration said on Wednesday that currently available COVID-19 vaccines are not well matched against the BA.2 sub-variant of Omicron, although booster doses help protect against severe outcomes.

The comments were made at a meeting of the FDA’s outside experts to discuss the timing of additional COVID-19 vaccine boosters and people eligible for extra shots.

Source: Read Full Article

Create Account

Log In Your Account